AnaptysBio Inc (NASDAQ:ANAB)

28.69
Delayed Data
As of Oct 15
 +0.38 / +1.34%
Today’s Change
17.72
Today|||52-Week Range
35.85
+33.44%
Year-to-Date
No recent news for AnaptysBio Inc.

Today’s Trading

Previous close28.31
Today’s open28.64
Day’s range28.25 - 28.80
Volume3,920
Average volume (3 months)188,870
Market cap$786.5M
Data as of 3:59pm ET, 10/15/2021

Growth & Valuation

Earnings growth (last year)+79.71%
Earnings growth (this year)-180.72%
Earnings growth (next 5 years)--
Revenue growth (last year)+837.50%
P/E ratioNM
Price/Sales7.83
Price/Book1.98

Competitors

----
VBIVVBI Vaccines Inc-0.04-1.30%
BTAIBioXcel Therapeutics...-0.66-2.38%
ADAPAdaptimmune Therapeu...-0.12-2.20%
Data as of 3:59pm ET, 10/15/2021

Financials

Next reporting dateNovember 11, 2021
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$75.0M
Annual profit (last year)-$19.9M
Net profit margin-26.57%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts